Developmentally regulated and evolutionarily conserved expression of SLITRK1 in brain circuits implicated in Tourette syndrome

Journal of Comparative Neurology

Volumn 513, Issue 1, 2009, Pages 21-37

  Stillman, Althea A ^a   Krsnik, Željka ^a   Sun, Jinhao ^a,c   Rašin, Mladen Roko ^a   State, Matthew W ^a,b   Şestan, Nenad ^a   Louvi, Angeliki ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c SHANDONG UNIVERSITY   (China)

Author keywords

Cholinergic neuron; Corticostriatal thalamocortical circuits; Dopamine; Pyramidal neuron; Striatum

Indexed keywords

4 AMINOBUTYRIC ACID; CALBINDIN; CALRETININ; CHOLINE ACETYLTRANSFERASE; DOPAMINE 1 RECEPTOR; ENKEPHALIN; GLIAL FIBRILLARY ACIDIC PROTEIN; MEMBRANE PROTEIN; MICROTUBULE ASSOCIATED PROTEIN 2; MU OPIATE RECEPTOR; NEURONAL NITRIC OXIDE SYNTHASE; PARVALBUMIN; RAB11 PROTEIN; SLIT PROTEIN AND BRAIN DERIVED NEUROTROPHIC FACTOR RECEPTOR LIKE FAMILY MEMBER 1; SUBSTANCE P; TRANSCRIPTION FACTOR FOXP2; UNCLASSIFIED DRUG; NERVE PROTEIN; SLITRK PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN DEVELOPMENT; BRAIN REGION; CHOLINERGIC NERVE CELL; CONTROLLED STUDY; CYTOPLASM VESICLE; EMBRYO; GENE EXPRESSION REGULATION; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC CONSERVATION; GENETIC VARIABILITY; GILLES DE LA TOURETTE SYNDROME; HUMAN; HUMAN CELL; HUMAN TISSUE; INTERNEURON; MONKEY; MOUSE; NERVE FIBER GROWTH; NEWBORN; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; PYRAMIDAL NERVE CELL; SPECIES DIFFERENCE; STRIATE CORTEX; THALAMOCORTICAL TRACT; ANIMAL; BRAIN; GENETICS; HISTOLOGY; IMMUNOHISTOCHEMISTRY; MACACA; METABOLISM; NERVE CELL; NERVE TRACT; ULTRASTRUCTURE;

ANIMALS; BRAIN; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HUMANS; IMMUNOHISTOCHEMISTRY; MACACA MULATTA; MEMBRANE PROTEINS; MICE; NERVE TISSUE PROTEINS; NEURAL PATHWAYS; NEURONS; TOURETTE SYNDROME;

EID: 59649102080     PISSN: 00219967     EISSN: 10969861     Source Type: Journal    
DOI: 10.1002/cne.21919     Document Type: Article

References (90)

1. Abelson JF, Kwan KY, O'Roak BJ, Baek DY, Stillman AA, Morgan TM, Mathews CA, Pauls DL, Rasin MR, Gunel M, Davis NR, Ercan-Sencicek AG, Guez DH, Spertus JA, Leckman JF, Dure LS, Kurlan R, Singer HS, Gilbert DL, Farhi A, Louvi A, Lifton RP, Sestan N, State MW. 2005. Sequence variants in SLITRK1 are associated with Tourette's syndrome. Science 310:317-320.
2. Albin RL, Mink JW. 2006. Recent advances in Tourette syndrome research. Trends Neurosci 29:175-182.
3. Albin RL, Koeppe RA, Bohnen NI, Nichols TE, Meyer P, Wernette K, Minoshima S, Kilbourn MR, Frey KA. 2003. Increased ventral striatal monoaminergic innervation in Tourette syndrome. Neurology 61:310-315.
4. Ang ES Jr, Haydar TF, Gluncic V, Rakic P. 2003. Four-dimensional migratory coordinates of GABAergic interneurons in the developing mouse cortex. J Neurosci 23:5805-5815.
5. Arlotta P, Molyneaux BJ, Chen J, Inoue J, Kominami R, Macklis JD. 2005. Neuronal subtype-specific genes that control corticospinal motor neuron development in vivo. Neuron 45:207-221.
6. Aruga J, Mikoshiba K. 2003. Identification and characterization of Slitrk, a novel neuronal transmembrane protein family controlling neurite outgrowth. Mol Cell Neurosci 24:117-129.
7. Aruga J, Yokota N, Mikoshiba K. 2003. Human SLITRK family genes: genomic organization and expression profiling in normal brain and brain tumor tissue. Gene 315:87-94.
8. Becker KP, Hannun YA. 2003. cPKC-dependent sequestration of membrane-recycling components in a subset of recycling endosomes. J Biol Chem 278:52747-52754.
9. Berardelli A, Curra A, Fabbrini G, Gilio F, Manfredi M. 2003. Pathophysiology of tics and Tourette syndrome. J Neurol 250:781-787.
10. Berg KA, Zardeneta G, Hargreaves KM, Clarke WP, Milam SB. 2007. Integrins regulate opioid receptor signaling in trigeminal ganglion neurons. Neuroscience 144:889-897.
11. Brandt MD, Jessberger S, Steiner B, Kronenberg G, Reuter K, Bick-Sander A, von der Behrens W, Kempermann G. 2003. Transient calretinin expression defines early postmitotic step of neuronal differentiation in adult hippocampal neurogenesis of mice. Mol Cell Neurosci 24:603-613.
12. Britanova O, de Juan Romero C, Cheung A, Kwan KY, Schwark M, Gyorgy A, Vogel T, Akopov S, Mitkovski M, Agoston D, Sestan N, Molnar Z, Tarabykin V. 2008. Satb2 is a postmitotic determinant for upper-layer neuron specification in the neocortex. Neuron 57:378-392.
13. Brose K, Bland KS, Wang KH, Arnott D, Henzel W, Goodman CS, Tessier-Lavigne M, Kidd T. 1999. Slit proteins bind Robo receptors and have an evolutionarily conserved role in repulsive axon guidance. Cell 96:795-806.
14. Bruce G, Wainer BH, Hersh LB. 1985. Immunoaffinity purification of human choline acetyltransferase: comparison of the brain and placental enzymes. J Neurochem 45:611-620.
15. Campbell MJ, Morrison JH. 1989. Monoclonal antibody to neurofilament protein (SMI-32) labels a subpopulation of pyramidal neurons in the human and monkey neocortex. J Comp Neurol 282:191-205.
16. Canales JJ, Graybiel AM. 2000. A measure of striatal function predicts motor stereotypy. Nat Neurosci 3:377-383.
17. Capani F, Ellisman MH, Martone ME. 2001. Filamentous actin is concentrated in specific subpopulations of neuronal and glial structures in rat central nervous system. Brain Res 923:1-11.
18. Capper-Loup C, Canales JJ, Kadaba N, Graybiel AM. 2002. Concurrent activation of dopamine D1 and D2 receptors is required to evoke neural and behavioral phenotypes of cocaine sensitization. J Neurosci 22: 6218-6227.
19. Cataldo AM, Petanceska S, Peterhoff CM, Terio NB, Epstein CJ, Villar A, Carlson EJ, Staufenbiel M, Nixon RA. 2003. App gene dosage modulates endosomal abnormalities of Alzheimer's disease in a segmental trisomy 16 mouse model of down syndrome. J Neurosci 23:6788-6792.
20. Celio MR, Baier W, Scharer L, de Viragh PA, Gerday C. 1988. Monoclonal antibodies directed against the calcium binding protein parvalbumin. Cell Calcium 9:81-86.
21. Cragg SJ. 2006. Meaningful silences: how dopamine listens to the ACh pause. Trends Neurosci 29:125-131.
22. Dotti CG, Banker GA, Binder LI. 1987. The expression and distribution of the microtubule-associated proteins tau and microtubule-associated protein 2 in hippocampal neurons in the rat in situ and in cell culture. Neuroscience 23:121-130.
23. Fazzari P, Penachioni J, Gianola S, Rossi F, Eickholt BJ, Maina F, Alexopoulou L, Sottile A, Comoglio PM, Flavell RA, Tamagnone L. 2007. Plexin-B1 plays a redundant role during mouse development and in tumour angiogenesis. BMC Dev Biol 7:55.
24. Ferland RJ, Cherry TJ, Preware PO, Morrisey EE, Walsh CA. 2003. Characterization of Foxp2 and Foxp1 mRNA and protein in the developing and mature brain. J Comp Neurol 460:266-279.
25. Fernandez-Chacon R, Wolfel M, Nishimune H, Tabares L, Schmitz F, Castellano-Munoz M, Rosenmund C, Montesinos ML, Sanes JR, Schneggenburger R, Sudhof TC. 2004. The synaptic vesicle protein CSP alpha prevents presynaptic degeneration. Neuron 42:237-251.
26. Fuentes-Santamaria V, Alvarado JC, Stein BE, McHaffie JG. 2008. Cortex contacts both output neurons and nitrergic interneurons in the superior colliculus: direct and indirect routes for multisensory integration. Cereb Cortex 18:1640-1652.
27. Fujimori K, Takauji R, Tamamaki N. 2002. Differential localization of high-and low-molecular-weight variants of microtubule-associated protein 2 in the developing rat telencephalon. J Comp Neurol 449:330-342.
28. Fujita E, Tanabe Y, Shiota A, Ueda M, Suwa K, Momoi MY, Momoi T. 2008. Ultrasonic vocalization impairment of Foxp2 (R552H) knockin mice related to speech-language disorder and abnormality of Purkinje cells. Proc Natl Acad Sci U S A 105:3117-3122.
29. Gabriel R, Witkovsky P. 1998. Cholinergic, but not the rod pathway-related glycinergic (All), amacrine cells contain calretinin in the rat retina. Neurosci Lett 247:179-182.
30. Garner CC, Tucker RP, Matus A. 1988. Selective localization of messenger RNA for cytoskeletal protein MAP2 in dendrites. Nature 336:674-677.
31. Gerfen CR. 1989. The neostriatal mosaic: striatal patch-matrix organization is related to cortical lamination. Science 246:385-388.
32. Gerfen CR. 2004. Basal ganglia. In: Paxinos G, editor. The rat nervous system. San Diego: Elsevier.
33. Gerfen CR, Young WS 3rd. 1988. Distribution of striatonigral and striato-pallidal peptidergic neurons in both patch and matrix compartments: an in situ hybridization histochemistry and fluorescent retrograde tracing study. Brain Res 460:161-167.
34. Goldstein ME, Sternberger LA, Sternberger NH. 1987. Varying degrees of phosphorylation determine microheterogeneity of the heavy neurofilament polypeptide (Nf-H). J Neuroimmunol 14:135-148.
35. Grosshans BL, Ortiz D, Novick P. 2006. Rabs and their effectors: achieving specificity in membrane traffic. Proc Natl Acad Sci U S A 103:11821-11827.
36. Grove EA, Tole S, Limon J, Yip L, Ragsdale CW. 1998. The hem of the embryonic cerebral cortex is defined by the expression of multiple Wnt genes and is compromised in Gli3-deficient mice. Development 125: 2315-2325.
37. Haber SN, Kowall NW, Vonsattel JP, Bird ED, Richardson EP Jr. 1986. Gilles de la Tourette's syndrome. A postmortem neuropathological and immunohistochemical study. J Neurol Sci 75:225-241.
38. Harris K, Singer HS. 2006. Tic disorders: neural circuits, neurochemistry, and neuroimmunology. J Child Neurol 21:678-689.
39. Haycock JW, Becker L, Ang L, Furukawa Y, Hornykiewicz O, Kish SJ. 2003. Marked disparity between age-related changes in dopamine and other presynaptic dopaminergic markers in human striatum. J Neurochem 87:574-585.
40. Herkenham M, Pert CB. 1981. Mosaic distribution of opiate receptors, parafascicular projections and acetylcholinesterase in rat striatum. Nature 291:415-418.
41. Hoekstra PJ, Anderson GM, Limburg PC, Korf J, Kallenberg CG, Minderaa RB. 2004. Neurobiology and neuroimmunology of Tourette's syndrome: an update. Cell Mol Life Sci 61:886-898.
42. Holt AG, Newman SW. 2004. Distribution of methionine and leucine enkephalin neurons within the social behavior circuitry of the male Syrian hamster brain. Brain Res 1030:28-48.
43. Hornse H, Banerjee S, Zeitlin H, Robertson M. 2001. The prevalence of Tourette syndrome in 13-14-year-olds in mainstream schools. J Child Psychol Psychiatry 42:1035-1039.
44. Joel D, Weiner I. 2000. The connections of the dopaminergic system with the striatum in rats and primates: an analysis with respect to the functional and compartmental organization of the striatum. Neuroscience 96:451-474.
45. Kalanithi PS, Zheng W, Kataoka Y, DiFiglia M, Grantz H, Saper CB, Schwartz ML, Leckman JF, Vaccarino FM. 2005. Altered parvalbumin-positive neuron distribution in basal ganglia of individuals with Tourette syndrome. Proc Natl Acad Sci U S A 102:13307-13312.
46. Kaneko S, Hikida T, Watanabe D, Ichinose H, Nagatsu T, Kreitman RJ, Pastan I, Nakanishi S. 2000. Synaptic integration mediated by striatal cholinergic interneurons in basal ganglia function. Science 289:633-637.
47. Katayama K, Yamada K, Ornthanalai VG, Inoue T, Ota M, Murphy NP, Aruga J. 2008. Slitrk1-deficient mice display elevated anxiety-like behavior and noradrenergic abnormalities. Mol Psychiatry (in press).
48. Lai CS, Fisher SE, Hurst JA, Vargha-Khadem F, Monaco AP. 2001. A forkhead-domain gene is mutated in a severe speech and language disorder. Nature 413:519-523.
49. Lai K, Kaspar BK, Gage FH, Schaffer DV. 2003. Sonic hedgehog regulates adult neural progenitor proliferation in vitro and in vivo. Nat Neurosci 6:21-27.
50. Leckman JF, Feldman R, Swain JE, Eicher V, Thompson N, Mayes LC. 2004. Primary parental preoccupation: circuits, genes, and the crucial role of the environment. J Neural Transm 111:753-771.
51. Leckman JF, Bloch MH, Scahill L, King RA. 2006a. Tourette syndrome: the self under siege. J Child Neurol 21:642-649.
52. Leckman JF, Vaccarino FM, Kalanithi PS, Rothenberger A. 2006b. Annotation: Tourette syndrome: a relentless drumbeat - driven by mis-guided brain oscillations. J Child Psychol Psychiatry 47:537-550.
53. Lee WC, Huang H, Feng G, Sanes JR, Brown EN, So PT, Nedivi E. 2006. Dynamic remodeling of dendritic arbors in GABAergic interneurons of adult visual cortex. PLoS Biol 4:e29.
54. Levey AI, Hersch SM, Rye DB, Sunahara RK, Niznik HB, Kitt CA, Price DL, Maggio R, Brann MR, Ciliax BJ, et al. 1993. Localization of D1 and D2 dopamine receptors in brain with subtype-specific antibodies. Proc Natl Acad Sci U S A 90:8861-8865.
55. Li HS, Chen JH, Wu W, Fagaly T, Zhou L, Yuan W, Dupuis S, Jiang ZH, Nash W, Gick C, Ornitz DM, Wu JY, Rao Y. 1999. Vertebrate slit, a secreted ligand for the transmembrane protein roundabout, is a repellent for olfactory bulb axons. Cell 96:807-818.
56. Linstedt AD, Hauri HP. 1993. Giantin, a novel conserved Golgi membrane protein containing a cytoplasmic domain of at least 350 kDa. Mol Biol Cell 4:679-693.
57. Lysakowski A, Wainer BH, Bruce G, Hersh LB. 1989. An atlas of the regional and laminar distribution of choline acetyltransferase immuno-reactivity in rat cerebral cortex. Neuroscience 28:291-336.
58. Marillat V, Cases O, Nguyen-Ba-Charvet KT, Tessier-Lavigne M, Sotelo C, Chedotal A. 2002. Spatiotemporal expression patterns of slit and robo genes in the rat brain. J Comp Neurol 442:130-155.
59. Miller M. 1981. Maturation of rat visual cortex. I. A quantitative study of Golgi-impregnated pyramidal neurons. J Neurocytol 10:859-878.
60. Morgado-Valle C, Feldman JL. 2004. Depletion of substance P and glutamate by capsaicin blocks respiratory rhythm in neonatal rat in vitro. J Physiol 555:783-792.
61. Nicola SM, Surmeier J, Malenka RC. 2000. Dopaminergic modulation of neuronal excitability in the striatum and nucleus accumbens. Annu Rev Neurosci 23:185-215.
62. Peterson BS, Skudlarski P, Anderson AW, Zhang H, Gatenby JC, Lacadie CM, Leckman JF, Gore JC. 1998. A functional magnetic resonance imaging study of tic suppression in Tourette syndrome. Arch Gen Psychiatry 55:326-333.
63. Peterson BS, Thomas P, Kane MJ, Scahill L, Zhang H, Bronen R, King RA, Leckman JF, Staib L. 2003. Basal ganglia volumes in patients with Gilles de la Tourette syndrome. Arch Gen Psychiatry 60:415-424.
64. Petit TL, LeBoutillier JC, Gregorio A, Libstug H. 1988. The pattern of dendritic development in the cerebral cortex of the rat. Brain Res 469:209-219.
65. Pisani A, Bernardi G, Ding J, Surmeier DJ. 2007. Re-emergence of striatal cholinergic interneurons in movement disorders. Trends Neurosci 30: 545-553.
66. Pla R, Borrell V, Flames N, Marin O. 2006. Layer acquisition by cortical GABAergic interneurons is independent of Reelin signaling. J Neurosci 26:6924-6934.
67. Polleux F, Morrow T, Ghosh A. 2000. Semaphorin 3A is a chemoattractant for cortical apical dendrites. Nature 404:567-573.
68. Rakic P, Goldman-Rakic PS. 1985. Use of fetal neurosurgery for experimental studies of structural and functional brain development in nonhuman primates. In: Thomson RA, Green JR, Johnsen SD, editors. Perinatal neurology and neurosurgery. New York: Spectrum. p 1-15.
69. Rasin MR, Gazula VR, Breunig JJ, Kwan KY, Johnson MB, Liu-Chen S, Li HS, Jan LY, Jan YN, Rakic P, Sestan N. 2007. Numb and Numbl are required for maintenance of cadherin-based adhesion and polarity of neural progenitors. Nat Neurosci 10:819-827.
70. Ren Z, Riley NJ, Garcia EP, Sanders JM, Swanson GT, Marshall J. 2003. Multiple trafficking signals regulate kainate receptor KA2 subunit surface expression. J Neurosci 23:6608-6616.
71. Robertson MM. 2003. Diagnosing Tourette syndrome: is it a common disorder? J Psychosom Res 55:3-6.
72. Rymar VV, Sasseville R, Luk KC, Sadikot AF. 2004. Neurogenesis and stereological morphometry of calretinin-immunoreactive GABAergic interneurons of the neostriatum. J Comp Neurol 469:325-339.
73. Saka E, Graybiel AM. 2003. Pathophysiology of Tourette's syndrome: striatal pathways revisited. Brain Dev 25(Suppl 1):S15-S19.
74. Singer HS. 2005. Tourette's syndrome: from behaviour to biology. Lancet Neurol 4:149-159.
75. Singer HS. 2006. Discussing outcome in Tourette syndrome. Arch Pediatr Adolesc Med 160:103-105.
76. Singer HS, Minzer K. 2003. Neurobiology of Tourette's syndrome: concepts of neuroanatomic localization and neurochemical abnormalities. Brain Dev 25(Suppl 1):S70-S84.
77. Sowell ER, Kan E, Yoshii J, Thompson PM, Bansal R, Xu D, Toga AW, Peterson BS. 2008. Thinning of sensorimotor cortices in children with Tourette syndrome. Nat Neurosci 11:637-639.
78. Spiteri E, Konopka G, Coppola G, Bomar J, Oldham M, Ou J, Vernes SC, Fisher SE, Ren B, Geschwind DH. 2007. Identification of the transcriptional targets of FOXP2, a gene linked to speech and language, in developing human brain. Am J Hum Genet 81:1144-1157.
79. State MW, Pauls DL, Leckman JF. 2001. Tourette's syndrome and related disorders. Child Adolesc Psychiatr Clin N Am 10:317-331, ix.
80. Sturrock RR. 1980. A comparative quantitative and morphological study of ageing in the mouse neostriatum, indusium griseum and anterior commissure. Neuropathol Appl Neurobiol 6:51-68.
81. Sun YG, Chen ZF. 2007. A gastrin-releasing peptide receptor mediates the itch sensation in the spinal cord. Nature 448:700-703.
82. Tole S, Patterson PH. 1995. Regionalization of the developing forebrain: a comparison of FORSE-1, Dlx-2, and BF-1. J Neurosci 15:970-980.
83. Topark-Ngarm A, Golonzhka O, Peterson VJ, Barrett B Jr, Martinez B, Crofoot K, Filtz TM, Leid M. 2006. CTIP2 associates with the NuRD complex on the promoter of p57KIP2, a newly identified CTIP2 target gene. J Biol Chem 281:32272-32283.
84. Whitford KL, Marillat V, Stein E, Goodman CS, Tessier-Lavigne M, Chedotal A, Ghosh A. 2002. Regulation of cortical dendrite development by Slit-Robo interactions. Neuron 33:47-61.
85. Woolf NJ. 1991. Cholinergic systems in mammalian brain and spinal cord. Prog Neurobiol 37:475-524.
86. Yung KK, Bolam JP, Smith AD, Hersch SM, Ciliax BJ, Levey AI. 1995. Immunocytochemical localization of D1 and D2 dopamine receptors in the basal ganglia of the rat: light and electron microscopy. Neuroscience 65:709-730.
87. Zheng H, McKay J, Buss JE. 2007. H-Ras does not need COP I- or COP II-dependent vesicular transport to reach the plasma membrane. J Biol Chem 282:25760-25768.
88. Zhou FC, Lesch KP, Murphy DL. 2002a. Serotonin uptake into dopamine neurons via dopamine transporters: a compensatory alternative. Brain Res 942:109-119.
89. Zhou FM, Wilson CJ, Dani JA. 2002b. Cholinergic interneuron characteristics and nicotinic properties in the striatum. J Neurobiol 53:590-605.
90. 2+-binding status and differences in antigen accessibility in colon cancer cells. Cell Calcium 31:13-25.